Skip to main content
Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.070
+0.020 (0.98%)
At close: Mar 9, 2026, 4:00 PM EDT
2.050
-0.020 (-0.97%)
After-hours: Mar 9, 2026, 8:00 PM EDT

Stereotaxis Revenue

Stereotaxis had revenue of $7.46M in the quarter ending September 30, 2025, a decrease of -18.83%. This brings the company's revenue in the last twelve months to $30.08M, up 19.62% year-over-year. In the year 2024, Stereotaxis had annual revenue of $26.92M with 0.55% growth.

Revenue (ttm)
$30.08M
Revenue Growth
+19.62%
P/S Ratio
6.42
Revenue / Employee
$216,367
Employees
139
Market Cap
193.18M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202426.92M147.00K0.55%
Dec 31, 202326.77M-1.38M-4.89%
Dec 31, 202228.15M-6.87M-19.63%
Dec 31, 202135.02M8.39M31.51%
Dec 31, 202026.63M-2.27M-7.86%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Embecta 1.08B
AngioDynamics 307.31M
OraSure Technologies 115.02M
Sanara MedTech 101.88M
Pro-Dex 72.10M
KORU Medical Systems 39.07M
Utah Medical Products 38.52M
Nyxoah 6.62M
Revenue Rankings

STXS News

More News